# Tyra Biosciences, Inc.: Form 8-K, filed Sep 15, 2026

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: 8-K
- Filed: 2026-09-15
- Accepted by EDGAR: Sep 14, 2026, 19:12 ET
- Period: 2026-09-14
- Accession: 0001193125-26-390951
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000119312526390951/d102025d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000119312526390951/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000119312526390951/d102025d8k.htm

Filed Sep 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-390951. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
